Skip to content

[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone

C17H14Cl3N5OS — CID 53387517

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone
SMILESO=C(c1cccnc1Nc1nc2c(Cl)cccc2s1)N1CCNC(Cl)C1Cl
InChIInChI=1S/C17H14Cl3N5OS/c18-10-4-1-5-11-12(10)23-17(27-11)24-15-9(3-2-6-22-15)16(26)25-8-7-21-13(19)14(25)20/h1-6,13-14,21H,7-8H2,(H,22,23,24)
InChIKeyIBWNRFBJYCBNFW-UHFFFAOYSA-N
MW442.76 g/mol
LogP4.26
Rot. Bonds3

About [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone

[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone (PubChem CID 53387517) has the molecular formula C17H14Cl3N5OS and a molecular weight of 442.76 g/mol. Its IUPAC name is [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone.

Molecular Properties

Compound Name[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone
PubChem CID53387517
Molecular FormulaC17H14Cl3N5OS
Molecular Weight442.76 g/mol
Exact Mass441.00
IUPAC Name[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone
SMILESO=C(c1cccnc1Nc1nc2c(Cl)cccc2s1)N1CCNC(Cl)C1Cl
InChIInChI=1S/C17H14Cl3N5OS/c18-10-4-1-5-11-12(10)23-17(27-11)24-15-9(3-2-6-22-15)16(26)25-8-7-21-13(19)14(25)20/h1-6,13-14,21H,7-8H2,(H,22,23,24)
InChIKeyIBWNRFBJYCBNFW-UHFFFAOYSA-N
XLogP4.26
TPSA70.15 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500442.76
LogP ≤ 54.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'}

Analyze [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone?
The IUPAC name of [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone (CID 53387517) is [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone.
What is the SMILES notation for [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone?
The canonical SMILES for [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone is O=C(c1cccnc1Nc1nc2c(Cl)cccc2s1)N1CCNC(Cl)C1Cl.
What is the InChIKey of [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone?
The InChIKey is IBWNRFBJYCBNFW-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H14Cl3N5OS/c18-10-4-1-5-11-12(10)23-17(27-11)24-15-9(3-2-6-22-15)16(26)25-8-7-21-13(19)14(25)20/h1-6,13-14,21H,7-8H2,(H,22,23,24).
What are the key properties of [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone?
[2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone has a molecular weight of 442.76 g/mol, XLogP of 4.26, 3 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(4-chloro-1,3-benzothiazol-2-yl)amino]-3-pyridinyl]-(2,3-dichloropiperazin-1-yl)methanone is sourced from PubChem (CID 53387517), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.